Drug Shortage Report for LITHANE
Report ID | 149009 |
Drug Identification Number | 00406775 |
Brand name | LITHANE |
Common or Proper name | LITHANE |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 CAPS |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-15 |
Actual start date | 2021-10-14 |
Estimated end date | 2021-12-28 |
Actual end date | 2022-03-01 |
Shortage status | Resolved |
Updated date | 2022-03-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-03-08 | French | Compare |
v3 | 2022-03-08 | English | Compare |
v2 | 2021-11-09 | French | Compare |
v1 | 2021-11-09 | English | Compare |
Showing 1 to 4 of 4